Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CRISPR
CRISPR
Editas halts lead CRISPR program after efficacy data underwhelm
Endpoints
Thu, 11/17/22 - 12:10 pm
Editas Medicine
CRISPR
EDIT-101
clinical trials
Only Patient in N-of-1 CRISPR Trial for Duchenne Muscular Dystrophy Dies
BioSpace
Mon, 11/7/22 - 10:45 am
CRISPR
clinical trials
patient deaths
Duchenne Muscular Dystrophy
CRD-TMH-001
Editas Rumored to be in “Advanced Discussions” around Potential Sale of Oncology Assets
BioSpace
Tue, 10/18/22 - 10:13 pm
Editas Medicine
gene editing
CRISPR
M&A
oncology
Vertex given green light to seek US approval of CRISPR-based therapy
BioPharma Dive
Wed, 09/28/22 - 12:01 am
Vertex Pharmaceuticals
CRISPR
CRISPR Therapeutics
FDA
exa-cel
beta thalassemia
sickle cell disease
Sanofi and Jennifer Doudna-Founded Scribe ink $1B CRISPR cell therapy deal
Pharma Live
Tue, 09/27/22 - 10:23 am
Sanofi
Scribe Therapeutics
CRISPR
Jennifer Doudna
gene editing
Intellia's Latest Data Indicate Full Potential of CRISPR
BioSpace
Sun, 09/18/22 - 10:31 pm
Intellia Therapeutics
ATTR amyloidosis
hereditary angiodema
CRISPR
Carver Bio Plants Seed to Treat Viral Threats with CRISPR Cas13
BioSpace
Thu, 09/15/22 - 11:20 pm
Carver Bio
CRISPR
funding
infectious diseases
RNA
gene therapy
CRISPR-Inspired Test Brings At-Home Diagnostics Closer to Reality
Medical Devices and Diagnostics Industry
Wed, 08/10/22 - 11:27 pm
Medtech
diagnostics
CrisprZyme
CRISPR
Cure Rare Disease Receives FDA Approval to Administer First-in-Human CRISPR Therapeutic
BioSpace
Wed, 08/10/22 - 10:42 am
Cure Rare Disease
non-profits
FDA
CRD-TMH-001
CRISPR
FDA halts testing of Beam’s base editing cancer therapy
BioPharma Dive
Mon, 08/1/22 - 10:45 am
Beam Therapeutics
clinical trials
FDA
gene editing
CRISPR
Editas treats first patient in sickle cell trial as FDA lifts partial hold
BioPharma Dive
Fri, 07/29/22 - 10:03 am
Editas Medicine
clinical trials
CRISPR
gene editing
sickle cell disease
Epic Bio, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine With Epigenetic Engineering
BioSpace
Tue, 07/12/22 - 10:49 am
Epic Bio
CRISPR
CAS protein
FSHD
CRISPR debuted 10 years ago, in a paper hardly anyone noticed. Jennifer Doudna reflects on the DNA scissors’ first decade
Stat
Tue, 06/28/22 - 10:31 am
CRISPR
gene editing
Jennifer Doudna
Pfizer-Backed DEM Bio Launches to Leverage CRISPR in Immuno-Oncology
BioSpace
Thu, 06/23/22 - 10:42 am
DEM BioPharma
CRISPR
immuno-oncology
Pfizer
New CRISPR-Based Map Opens Door to New Genetic Testing, Therapeutic Possibilities
BioSpace
Mon, 06/13/22 - 10:36 am
CRISPR
gene mapping
genetics
The hangover: Caribou's allogeneic CAR-T hit by durability doubts as half of patients relapse
Fierce Biotech
Fri, 06/10/22 - 10:55 am
Caribou Biosciences
CRISPR
CAR-T
allogenic CAR-T
EHA
non-Hodgkin's lymphoma
Immatics and Editas join up to bring CRISPR to 'gamma delta' cell therapy
BioPharma Dive
Tue, 06/7/22 - 10:22 am
Editas Medicine
CRISPR
gene editing
Immatics
gamma delta cell therapy
Researchers develop CRISPR mechanism to edit multiple DNA sites at once
BioSpace
Fri, 05/20/22 - 10:50 am
Rice University
gene editing
CRISPR
drive and process arrays
Biogen takes another dip into Scribe gene therapy collab with another disease target
Fierce Biotech
Mon, 05/2/22 - 06:18 pm
Biogen
Scribe Therapeutics
gene therapy
CRISPR
Editas sees clinical promise with new FDA pediatric disease tag for another blood disorder
Fierce Biotech
Tue, 04/26/22 - 10:15 pm
Editas Medicine
EDIT-301
CRISPR
beta thalassemia
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »